Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
C., van den Heuvel, E
Presented for research literature review only Channabasappa S et al
The LCLT group had a slight decrease (but not significant) in platelet count from day 7 to day 14, whereas the placebo group did not have a similar decrease
In cardiomyocytes, GLP-1R activation has no significant effect on myocardial glucose metabolism under nonischemic conditions [23], but there is an increased expression of oxidative phosphorylation protein and a simultaneous downregulation of glycolysis pathways during the early phases of myocardial infarction [24]
Here are some of the potential side effects and possible risks
Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, et al: GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE/ Mice
